Walvax Biotechnology Co., Ltd. Stock

Equities

300142

CNE100000WN2

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-06-17 EDT 5-day change 1st Jan Change
11.95 CNY -2.37% Intraday chart for Walvax Biotechnology Co., Ltd. -6.71% -49.17%

Financials

Sales 2024 * 4.13B 569M 781M Sales 2025 * 4.85B 669M 917M Capitalization 19.09B 2.63B 3.61B
Net income 2024 * 781M 108M 148M Net income 2025 * 1.01B 140M 191M EV / Sales 2024 * 3.61 x
Net cash position 2024 * 4.17B 575M 788M Net cash position 2025 * 4.77B 657M 900M EV / Sales 2025 * 2.95 x
P/E ratio 2024 *
24.4 x
P/E ratio 2025 *
19 x
Employees 2,388
Yield 2024 *
0.84%
Yield 2025 *
1%
Free-Float 85.34%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.37%
1 week-6.71%
Current month-10.55%
1 month-17.59%
3 months-34.16%
6 months-45.80%
Current year-49.17%
More quotes
1 week
11.90
Extreme 11.9
12.91
1 month
11.90
Extreme 11.9
14.75
Current year
11.90
Extreme 11.9
23.66
1 year
11.90
Extreme 11.9
28.45
3 years
11.90
Extreme 11.9
96.73
5 years
11.90
Extreme 11.9
96.73
10 years
5.05
Extreme 5.0533
96.73
More quotes
Managers TitleAgeSince
President 67 16-06-21
Director of Finance/CFO 57 14-06-22
Director/Board Member 56 22-01-26
Members of the board TitleAgeSince
Director/Board Member 61 02-12-31
Chairman 62 09-06-22
Director/Board Member 57 09-06-22
More insiders
Date Price Change Volume
24-06-18 11.95 -2.37% 22,851,720
24-06-17 12.24 -1.84% 16,043,930
24-06-14 12.47 -2.50% 24,339,960
24-06-13 12.79 -0.78% 12,939,200
24-06-12 12.89 +0.62% 15,238,910

End-of-day quote Shenzhen S.E., June 17, 2024

More quotes
Walvax Biotechnology Co. specialises in the research, development, manufacturing and marketing of human vaccines. Products include vaccines against haemophilus influenzae, meningitis, septicaemia, meningococcal disease, etc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
11.95 CNY
Average target price
18 CNY
Spread / Average Target
+50.63%
Consensus
  1. Stock Market
  2. Equities
  3. 300142 Stock